JournalsHub
.online
Find My Journal
EL

Esther ter Linden

Oncode Institute NL

3
Publications
36
Citations
2
H-Index
1
i10-Index
14.0
2yr Mean Cite
True
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

3 total

Overcoming Barriers in Glioblastoma—Advances in Drug Delivery Strategies PDF

Esther ter Linden, Erik R. Abels, Thomas S. van Solinge, Jacques Neefjes, Marike L. D. Broekman - Cells, 2024
Cited by 27 OpenAlex

Temozolomide and Lomustine Induce Tissue Factor Expression and Procoagulant Activity in Glioblastoma Cells In Vitro PDF

Maaike Y. Kapteijn, Shanna Zwaan, Esther ter Linden, El Houari Laghmani, Rob F. P. van den Akker et al. - Cancers, 2023
Cited by 8 OpenAlex

TEMPORARY REMOVAL: PO-30: Chemotherapeutic agents temozolomide and lomustine induce procoagulant activity of glioblastoma cell lines in vitro.

M. Kapteijn, S. Zwaan, E. ter Linden, R. V. D. van den Akker, A. Rondon - Thrombosis Research, 2022
Cited by 0 Semantic Scholar

Medullary Pancreatic Carcinoma Due to Somatic POLE Mutation OA

Valentyna Kryklyva, E. ter Linden, L. Kroeze, Richarda M. de Voer, B. Marion van der Kolk - Pancreas, 2020
Cited by 20 Semantic Scholar

Research Topics

Nanoparticle-Based Drug Delivery (1) Glioma Diagnosis and Treatment (1) Pancreatic and Hepatic Oncology Research (1) Venous Thromboembolism Diagnosis and Management (1) Cancer Cells and Metastasis (1)

Affiliations

Leiden University Medical Center
NL 2024 - 2023
Oncode Institute
NL 2025 - 2023

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now